î
îŒ
ãã°ã€ã³
î
Teva Pharmaceutical Industries Ltd
TEVA29.465USD
+0.695+2.42%
çµå€Â 03/25, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
33.88Bæ䟡ç·é¡
23.93çŽè¿12ã¶æPER
î
詳现æ å ± Teva Pharmaceutical Industries Ltd äŒæ¥å
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Teva Pharmaceutical Industries Ltdã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãTEVA
äŒç€ŸåTeva Pharmaceutical Industries Ltd
äžå Žæ¥Feb 06, 2087
æé«çµå¶è²¬ä»»è
ãCEOãFrancis (Richard D)
åŸæ¥å¡æ°33892
蚌åžçš®é¡Depository Receipt
決ç®ææ«Feb 06
æ¬ç€Ÿæåšå°124 Dvora Hanevi'a St.
éœåžTEL AVIV-YAFO
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœIsrael
éµäŸ¿çªå·6944020
é»è©±çªå·97239148213
ãŠã§ããµã€ãhttps://www.tevapharm.com/
äŒæ¥ã³ãŒãTEVA
äžå Žæ¥Feb 06, 2087
æé«çµå¶è²¬ä»»è
ãCEOãFrancis (Richard D)
Teva Pharmaceutical Industries Ltdã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+42.80%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
--
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
--
--
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Director
Independent Director
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Mr. Roberto A. Mignone
Mr. Roberto A. Mignone
Independent Director
Independent Director
--
--
Dr. Perry D. Nisen, M.D., Ph.D.
Dr. Perry D. Nisen, M.D., Ph.D.
Independent Director
Independent Director
--
--
詳现ãèŠã
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+42.80%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
--
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
--
--
åçå èš³
é貚: USDæŽæ°æå»: Tue, Jan 6
é貚: USDæŽæ°æå»: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
äºæ¥å¥USD
äŒç€Ÿå
åç
æ¯ç
Generic products
2.58B
57.54%
AUSTEDO
609.00M
13.59%
Anda
392.00M
8.75%
Other
274.00M
6.12%
AJOVY
169.00M
3.77%
ä»ã®
458.00M
10.22%
å°åå¥USD
äŒç€Ÿå
åç
æ¯ç
United States
2.48B
55.40%
Europe
1.24B
27.57%
International Markets
558.00M
12.46%
Other
205.00M
4.58%
äºæ¥å¥
å°åå¥
äºæ¥å¥USD
äŒç€Ÿå
åç
æ¯ç
Generic products
2.58B
57.54%
AUSTEDO
609.00M
13.59%
Anda
392.00M
8.75%
Other
274.00M
6.12%
AJOVY
169.00M
3.77%
ä»ã®
458.00M
10.22%
æ ªäž»
æŽæ°æå»: Sat, Feb 21
æŽæ°æå»: Sat, Feb 21
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Harel Insurance Investments and Financial Services Ltd
3.86%
Phoenix Investment and Finances Ltd
3.53%
Menora Mivtachim Insurance Ltd.
3.38%
Clal Insurance Enterprises Holdings Ltd.
3.21%
Migdal Insurance and Financial Holdings Ltd
3.21%
ä»ã®
82.81%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Harel Insurance Investments and Financial Services Ltd
3.86%
Phoenix Investment and Finances Ltd
3.53%
Menora Mivtachim Insurance Ltd.
3.38%
Clal Insurance Enterprises Holdings Ltd.
3.21%
Migdal Insurance and Financial Holdings Ltd
3.21%
ä»ã®
82.81%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Investment Advisor
25.38%
Investment Advisor/Hedge Fund
12.78%
Hedge Fund
6.70%
Insurance Company
6.60%
Sovereign Wealth Fund
3.06%
Research Firm
2.15%
Pension Fund
1.75%
Bank and Trust
0.96%
Family Office
0.91%
ä»ã®
39.71%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Thu, Jan 1
æŽæ°æå»: Thu, Jan 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2025Q4
1170
665.23M
57.84%
-137.26M
2025Q3
1124
742.23M
64.70%
-84.92M
2025Q2
1100
749.18M
65.31%
-13.97M
2025Q1
1130
727.69M
63.46%
-282.41K
2024Q4
1087
683.52M
59.66%
-22.86M
2024Q3
1029
663.95M
58.60%
-6.13M
2024Q2
1002
631.05M
55.72%
-26.20M
2024Q1
950
595.83M
53.15%
-34.73M
2023Q4
932
601.27M
53.63%
+7.51M
2023Q3
929
573.53M
51.16%
-84.22M
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Harel Insurance Investments and Financial Services Ltd
37.70M
3.29%
+4.31M
+12.90%
Sep 30, 2025
Phoenix Investment and Finances Ltd
41.30M
3.6%
+3.53M
+9.36%
Sep 30, 2025
Menora Mivtachim Insurance Ltd.
38.92M
3.39%
-18.47M
-32.19%
Sep 30, 2025
Clal Insurance Enterprises Holdings Ltd.
31.49M
2.74%
-876.00K
-2.71%
Sep 30, 2025
Migdal Insurance and Financial Holdings Ltd
32.58M
2.84%
+3.90M
+13.58%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
34.92M
3.04%
+1.03M
+3.04%
Sep 30, 2025
Lingotto Investment Management LLP
28.59M
2.49%
+431.87K
+1.53%
Sep 30, 2025
Fidelity Management & Research Company LLC
20.19M
1.76%
-30.45M
-60.13%
Sep 30, 2025
Rubric Capital Management LP
24.65M
2.15%
-1.35M
-5.19%
Sep 30, 2025
詳现ãèŠã
é¢é£ETF
îæŽæ°æå»: Sat, Dec 6
æŽæ°æå»: Sat, Dec 6
éæå
æ¯ç
iShares MSCI Israel ETF
7.76%
VanEck Israel ETF
7.5%
VanEck Pharmaceutical ETF
3.79%
First Trust WCM Developing World Equity ETF
3.16%
First Trust WCM International Equity ETF
2.64%
ARK Israel Innovative Technology ETF
1.81%
WealthTrust DBS Long Term Growth ETF
1.42%
WisdomTree International Multifactor Fund
0.77%
iShares Health Innovation Active ETF
0.69%
iShares MSCI Intl Value Factor ETF
0.46%
詳现ãèŠã
iShares MSCI Israel ETF
æ¯ç7.76%
VanEck Israel ETF
æ¯ç7.5%
VanEck Pharmaceutical ETF
æ¯ç3.79%
First Trust WCM Developing World Equity ETF
æ¯ç3.16%
First Trust WCM International Equity ETF
æ¯ç2.64%
ARK Israel Innovative Technology ETF
æ¯ç1.81%
WealthTrust DBS Long Term Growth ETF
æ¯ç1.42%
WisdomTree International Multifactor Fund
æ¯ç0.77%
iShares Health Innovation Active ETF
æ¯ç0.69%
iShares MSCI Intl Value Factor ETF
æ¯ç0.46%
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
æ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
